Business Context and Reporting Period
Company: Pavmed Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 3, 2021
Reporting Period: Single event date (August 3, 2021)
Business Context: Pavmed Inc. is an emerging growth company incorporated in Delaware. The filing discloses a corporate governance update regarding its majority-owned subsidiary, Lucid Diagnostics Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is a current report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
Board Appointment: On August 3, 2021, Aster Angagaw joined the Board of Directors of Lucid Diagnostics Inc., a majority-owned subsidiary of Pavmed Inc.
Guidance, Outlook, and Risks
Management Commentary: The filing serves as a Regulation FD disclosure to announce the board appointment. No financial guidance, outlook, or risk factors were discussed in this specific report.
Unusual Items: None reported beyond the standard corporate governance update.
Investor Verification Checklist
- Verify the background and qualifications of Aster Angagaw, the new board member for Lucid Diagnostics Inc.
- Confirm the ownership percentage Pavmed Inc. holds in Lucid Diagnostics Inc. to assess the materiality of this governance change.
- Review the attached press release (Exhibit 99.1) for additional context on the appointment.
- Note that this filing does not contain financial data; refer to the most recent 10-Q or 10-K for financial performance.